Bjoern Moosmann

1.7k total citations
37 papers, 1.3k citations indexed

About

Bjoern Moosmann is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Bjoern Moosmann has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Toxicology, 20 papers in Pharmacology and 17 papers in Clinical Psychology. Recurrent topics in Bjoern Moosmann's work include Forensic Toxicology and Drug Analysis (34 papers), Cannabis and Cannabinoid Research (20 papers) and Psychedelics and Drug Studies (17 papers). Bjoern Moosmann is often cited by papers focused on Forensic Toxicology and Drug Analysis (34 papers), Cannabis and Cannabinoid Research (20 papers) and Psychedelics and Drug Studies (17 papers). Bjoern Moosmann collaborates with scholars based in Germany, Switzerland and Australia. Bjoern Moosmann's co-authors include Volker Auwärter, Verena Angerer, Florian Franz, Laura M. Huppertz, Philippe Bisel, Stefan Kneisel, Melanie Hutter, Folker Westphal, Volker Brecht and Armin Buchwald and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Analytica Chimica Acta.

In The Last Decade

Bjoern Moosmann

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bjoern Moosmann Germany	22	1.1k	640	438	379	266	37	1.3k
Folker Westphal Germany	25	1.2k 1.1×	578 0.9×	777 1.8×	478 1.3×	217 0.8×	74	1.7k
Marisol S. Castaneto United States	16	902 0.8×	715 1.1×	289 0.7×	263 0.7×	258 1.0×	22	1.1k
Jérémy Carlier Italy	21	585 0.5×	585 0.9×	208 0.5×	207 0.5×	166 0.6×	67	1.3k
Ariane Wohlfarth United States	30	1.6k 1.4×	956 1.5×	381 0.9×	386 1.0×	591 2.2×	51	2.0k
Florian Franz Germany	20	808 0.7×	590 0.9×	279 0.6×	325 0.9×	181 0.7×	29	1.0k
Sarah Kerrigan United States	22	703 0.6×	356 0.6×	259 0.6×	155 0.4×	232 0.9×	68	1.3k
Ritva Karinen Norway	22	900 0.8×	275 0.4×	242 0.6×	178 0.5×	420 1.6×	56	1.4k
Simon Hudson United Kingdom	20	802 0.7×	490 0.8×	348 0.8×	264 0.7×	122 0.5×	42	1.1k
Madeleine J. Swortwood United States	20	590 0.5×	507 0.8×	179 0.4×	174 0.5×	158 0.6×	43	1.0k
Piotr Adamowicz Poland	25	1.1k 1.0×	367 0.6×	556 1.3×	353 0.9×	264 1.0×	48	1.3k

Countries citing papers authored by Bjoern Moosmann

Since Specialization

Citations

This map shows the geographic impact of Bjoern Moosmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjoern Moosmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjoern Moosmann more than expected).

Fields of papers citing papers by Bjoern Moosmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjoern Moosmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjoern Moosmann. The network helps show where Bjoern Moosmann may publish in the future.

Co-authorship network of co-authors of Bjoern Moosmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bjoern Moosmann. A scholar is included among the top collaborators of Bjoern Moosmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjoern Moosmann. Bjoern Moosmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moosmann, Bjoern, et al.. (2022). Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles. Analytica Chimica Acta. 1219. 339978–339978. 7 indexed citations

Moosmann, Bjoern & Volker Auwärter. (2018). Designer Benzodiazepines: Another Class of New Psychoactive Substances. Handbook of experimental pharmacology. 252. 383–410. 62 indexed citations

Angerer, Verena, Florian Franz, Bjoern Moosmann, Philippe Bisel, & Volker Auwärter. (2018). 5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA. Forensic Toxicology. 37(1). 186–196. 32 indexed citations

Moosmann, Bjoern, et al.. (2017). Semi-quantitative determination of designer benzodiazepines in serum by adaption of an automated LC-MSn screening approach. Annales de Toxicologie Analytique. 29(2). S59–S60. 3 indexed citations

Franz, Florian, Verena Angerer, Christian Schlögl, et al.. (2017). Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 55(9). 1375–1384. 45 indexed citations

Mogler, Lukas, Florian Franz, Daniel Rentsch, et al.. (2017). Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples. Drug Testing and Analysis. 10(1). 196–205. 87 indexed citations

Huppertz, Laura M., Bjoern Moosmann, & Volker Auwärter. (2017). Flubromazolam – Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Drug Testing and Analysis. 10(1). 206–211. 49 indexed citations

Allison, Sarah E., Yongjuan Chen, Nenad Petrović, et al.. (2016). Activation of the pro-migratory bone morphogenetic protein receptor 1B gene in human MDA-MB-468 triple-negative breast cancer cells that over-express CYP2J2. The International Journal of Biochemistry & Cell Biology. 80. 173–178. 9 indexed citations

Angerer, Verena, Philippe Bisel, Bjoern Moosmann, Folker Westphal, & Volker Auwärter. (2016). Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative NE-CHMIMO using flash chromatography, GC-MS, IR and NMR spectroscopy. Forensic Science International. 266. e93–e98. 22 indexed citations

10.

Franz, Florian, Verena Angerer, Maren Hermanns‐Clausen, Volker Auwärter, & Bjoern Moosmann. (2016). Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?. Analytical and Bioanalytical Chemistry. 408(13). 3445–3452. 48 indexed citations

11.

Moosmann, Bjoern, et al.. (2015). Finding cannabinoids in hair does not prove cannabis consumption. Scientific Reports. 5(1). 14906–14906. 46 indexed citations

12.

Auwärter, Volker, et al.. (2014). O23: Hair analysis for synthetic cannabinoids: How does handling of herbal mixtures during forensic analysis affect the analyst's hair concentrations?. Annales de Toxicologie Analytique. 26(2). S14–S14. 1 indexed citations

13.

Koller, Verena Juliana, Volker Auwärter, Tamara Grummt, et al.. (2014). Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8. Toxicology and Applied Pharmacology. 277(2). 164–171. 48 indexed citations

14.

Hutter, Melanie, Bjoern Moosmann, Volker Auwärter, & Merja A. Neukamm. (2014). Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke. Forensic Toxicology. 33(1). 69–76. 12 indexed citations

15.

Moosmann, Bjoern, et al.. (2014). Hair analysis of synthetic cannabinoids: does the handling of herbal mixtures affect the analyst’s hair concentration?. Forensic Toxicology. 33(1). 37–44. 13 indexed citations

16.

Moosmann, Bjoern, et al.. (2014). Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9‐tetrahydrocannabinolic acid A concentrations. Drug Testing and Analysis. 7(5). 349–357. 29 indexed citations

17.

Kneisel, Stefan, et al.. (2013). LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Analytical and Bioanalytical Chemistry. 405(14). 4691–4706. 55 indexed citations

18.

Moosmann, Bjoern, et al.. (2013). Development and validation of an LC‐MS/MS method for quantification of Δ9‐tetrahydrocannabinolic acid A (THCA‐A), THC, CBN and CBD in hair. Journal of Mass Spectrometry. 48(2). 227–233. 45 indexed citations

19.

Moosmann, Bjoern, Stefan Kneisel, Ariane Wohlfarth, Volker Brecht, & Volker Auwärter. (2012). A fast and inexpensive procedure for the isolation of synthetic cannabinoids from ‘Spice’ products using a flash chromatography system. Analytical and Bioanalytical Chemistry. 405(12). 3929–3935. 17 indexed citations

20.

Moosmann, Bjoern, Stefan Kneisel, Ulrich Girreser, et al.. (2012). Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system. Forensic Science International. 220(1-3). e17–e22. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact